These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 5600777

  • 41. Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus.
    Eblé PL, Bouma A, de Bruin MG, van Hemert-Kluitenberg F, van Oirschot JT, Dekker A.
    Vaccine; 2004 Mar 29; 22(11-12):1372-8. PubMed ID: 15063559
    [Abstract] [Full Text] [Related]

  • 42. [Comparison of a bivalent anti-foot-and-mouth disease vaccine with oil adjuvant to a vaccine with DEAE-dextran adjuvant in swine].
    Kihm U.
    Dev Biol Stand; 1976 Mar 29; 35():149-53. PubMed ID: 198281
    [Abstract] [Full Text] [Related]

  • 43. Poly(I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs.
    Cao Y, Lu Z, Li Y, Sun P, Li D, Li P, Bai X, Fu Y, Bao H, Zhou C, Xie B, Chen Y, Liu Z.
    Antiviral Res; 2013 Feb 29; 97(2):145-53. PubMed ID: 23219974
    [Abstract] [Full Text] [Related]

  • 44. Vaccination of pigs with formaldehyde inactivated aluminium hydroxide foot-and-mouth disease vaccines, potentiated with diethylaminoethyldextran (DEAE-D).
    de Leeuw PW, Tiessink JW, Frenkel S.
    Zentralbl Veterinarmed B; 1979 Mar 29; 26(2):85-97. PubMed ID: 231355
    [No Abstract] [Full Text] [Related]

  • 45. Rational design and efficacy of a multi-epitope recombinant protein vaccine against foot-and-mouth disease virus serotype A in pigs.
    Cao Y, Li D, Fu Y, Bai Q, Chen Y, Bai X, Jing Z, Sun P, Bao H, Li P, Zhang J, Ma X, Lu Z, Liu Z.
    Antiviral Res; 2017 Apr 29; 140():133-141. PubMed ID: 28161579
    [Abstract] [Full Text] [Related]

  • 46. [Experience in anti-aphthous vaccination in pigs].
    Dhennin L, Gayot G.
    Bull Acad Vet Fr; 1967 Nov 29; 40(9):441-5. PubMed ID: 4314655
    [No Abstract] [Full Text] [Related]

  • 47. [Research on foot-and-mouth disease vaccination of swine (trial of a trivalent O A C vaccine)].
    Giraud M, Berson JP, Loquerie R, Guerche J, Prunet P, Dhennin L, Dhennin L.
    Bull Acad Vet Fr; 1970 Jul 29; 43(7):335-43. PubMed ID: 5534317
    [No Abstract] [Full Text] [Related]

  • 48. Studies with divinyl ether-maleic anhydride and foot-and-mouth disease vaccines in swine.
    Campbell CH, Richmond JY, McKercher PD.
    Arch Gesamte Virusforsch; 1974 Jul 29; 46(3-4):334-40. PubMed ID: 4375451
    [No Abstract] [Full Text] [Related]

  • 49. [Attempted vaccination of swine with inactive aphthous virus vaccines. I. Tests of O virus inactivated with hydroxylamine, formol, heat and pH].
    Wittmann G, Bauer K, Mussgay M.
    Bull Off Int Epizoot; 1969 Jul 29; 71(3-4):351-79. PubMed ID: 4323525
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Enhancement of DNA vaccine (P12A3C-pcDNA) efficacy against foot-and-mouth disease by coadministration of interleukin-18-expressing (IL18 pcDNA) plasmid in guinea-pigs.
    Siva Reddy K, Muralidhar Rao D, Badrinaryana N, Suryanaryana VV, Reddy GR.
    FEMS Immunol Med Microbiol; 2010 Dec 29; 60(3):261-9. PubMed ID: 21039923
    [Abstract] [Full Text] [Related]

  • 52. Immune responses of swine inoculated with a recombinant fowlpox virus co-expressing P12A and 3C of FMDV and swine IL-18.
    Ma M, Jin N, Shen G, Zhu G, Liu HJ, Zheng M, Lu H, Huo X, Jin M, Yin G, Ma H, Li X, Ji Y, Jin K.
    Vet Immunol Immunopathol; 2008 Jan 15; 121(1-2):1-7. PubMed ID: 17706296
    [Abstract] [Full Text] [Related]

  • 53. Saponin adjuvants. VI. The adjuvant activity of quil A in trivalent vaccination of cattle and guinea pigs against foot-and-mouth disease.
    Dalsgaard K, Jensen MH.
    Acta Vet Scand; 1977 Jan 15; 18(3):367-73. PubMed ID: 910658
    [Abstract] [Full Text] [Related]

  • 54. A study on the immune response of sheep to foot and mouth disease virus vaccine type 'O' prepared with different inactivants and adjuvants.
    Nair SP, Sen AK.
    Acta Virol; 1992 Oct 15; 36(5):473-8. PubMed ID: 1364024
    [Abstract] [Full Text] [Related]

  • 55. [Some current questions regarding control of foot and mouth disease].
    Benndorf E.
    Monatsh Veterinarmed; 1970 Mar 15; 25(6):215-8. PubMed ID: 5534896
    [No Abstract] [Full Text] [Related]

  • 56. Protection of a novel epitope-RNA VLP double-effective VLP vaccine for foot-and-mouth disease.
    Dong YM, Cai JC, Chen HT, Chen L.
    Antiviral Res; 2016 Oct 15; 134():108-116. PubMed ID: 27565990
    [Abstract] [Full Text] [Related]

  • 57. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
    Lu Z, Bao H, Cao Y, Sun P, Guo J, Li P, Bai X, Chen Y, Xie B, Li D, Liu Z, Xie Q.
    Vaccine; 2008 Dec 19; 26 Suppl 6():G48-53. PubMed ID: 19178894
    [Abstract] [Full Text] [Related]

  • 58. [Area vaccinations against foot and mouth disease in the Cloppenburg and Vechta counties in Oldenburg].
    Ochsenfahrt K, Prange H.
    Dtsch Tierarztl Wochenschr (1946); 1967 May 01; 74(9):220-5. PubMed ID: 6069022
    [No Abstract] [Full Text] [Related]

  • 59. Current status of foot-and-mouth disease vaccines including the use of genetic engineering.
    Della-Porta AJ.
    Aust Vet J; 1983 May 01; 60(5):129-35. PubMed ID: 6311153
    [No Abstract] [Full Text] [Related]

  • 60. Quantities of purified antigen required to immunize swine against foot-and-mouth disease.
    Mowat GN.
    Bull Off Int Epizoot; 1972 May 01; 77(5):887-97. PubMed ID: 4676701
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.